These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 28925386)

  • 21. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
    Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
    Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.
    Tong X; Chen W; Ye L; Xiong Y; Xu Y; Luo Y; Xia X; Xu Z; Lin Y; Zhu X; Wang N; Xue X; Zhang H; Guo G
    Lupus Sci Med; 2024 Oct; 11(2):. PubMed ID: 39366755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
    Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
    Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications.
    Li JJN; Liu G; Lok BH
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor DNA 5-hydroxymethylcytosine as a novel diagnostic biomarker for esophageal cancer.
    Tian X; Sun B; Chen C; Gao C; Zhang J; Lu X; Wang L; Li X; Xing Y; Liu R; Han X; Qi Z; Zhang X; He C; Han D; Yang YG; Kan Q
    Cell Res; 2018 May; 28(5):597-600. PubMed ID: 29467383
    [No Abstract]   [Full Text] [Related]  

  • 27. Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers.
    Wang Z; Du M; Yuan Q; Guo Y; Hutchinson JN; Su L; Zheng Y; Wang J; Mucci LA; Lin X; Hou L; Christiani DC
    Neoplasia; 2020 Mar; 22(3):154-161. PubMed ID: 32062069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
    Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
    Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of 5-methylcytosine, 5-hydroxymethylcytosine and 5-carboxylcytosine from the blood of cancer patients by an enzyme-based immunoassay.
    Chowdhury B; Cho IH; Hahn N; Irudayaraj J
    Anal Chim Acta; 2014 Dec; 852():212-7. PubMed ID: 25441900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
    Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
    Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
    Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
    Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer.
    Shao J; Xu Y; Olsen RJ; Kasparian S; Sun K; Mathur S; Zhang J; He C; Chen SH; Bernicker EH; Li Z
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
    Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
    Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA.
    Guler GD; Ning Y; Ku CJ; Phillips T; McCarthy E; Ellison CK; Bergamaschi A; Collin F; Lloyd P; Scott A; Antoine M; Wang W; Chau K; Ashworth A; Quake SR; Levy S
    Nat Commun; 2020 Oct; 11(1):5270. PubMed ID: 33077732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.
    Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K
    Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
    Applebaum MA; Barr EK; Karpus J; West-Szymanski DC; Oliva M; Sokol EA; Zhang S; Zhang Z; Zhang W; Chlenski A; Salwen HR; Wilkinson E; Dobratic M; Grossman RL; Godley LA; Stranger BE; He C; Cohn SL
    Clin Cancer Res; 2020 Mar; 26(6):1309-1317. PubMed ID: 31852832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-Free DNA: Applications in Different Diseases.
    Ranucci R
    Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis.
    Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.